Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Huland

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Journal of Cancer Research and Clinical Oncology|January 1, 1992
Tumor-associated eosinophilia in interleukin-2-treated patients: evidence of toxic eosinophil degranulation on bladder cancer cellsE Huland, H Huland
Cancer Research|October 1, 1989
Local continuous high dose interleukin 2: a new therapeutic model for the treatment of advanced bladder carcinomaE Huland, H Huland
Der Urologe. Ausg. A|July 23, 2002
[Regional immunotherapy of metastatic renal cell carcinoma]H Heinzer, E Huland, H Huland
Folia Biologica|January 5, 2001
A comparison of systemic versus inhaled recombinant IL-2 administration for the treatment of metastatic renal cell carcinomaE Huland, H Heinzer, H Huland
Journal of Cancer Research and Clinical Oncology|January 1, 1994
Inhaled interleukin-2 in combination with low-dose systemic interleukin-2 and interferon alpha in patients with pulmonary metastatic renal-cell carcinoma: effectiveness and toxicity of mainly local treatmentE Huland, H Heinzer, H Huland
Der Urologe. Ausg. A|November 19, 2003
[Immunotherapy of renal cell carcinoma. With special emphasis on therapy of the elderly patient]H Heinzer, E Huland, H Huland
Anticancer Research|September 2, 1999
Treatment of pulmonary metastatic renal-cell carcinoma in 116 patients using inhaled interleukin-2 (IL-2)E Huland, H Heinzer, H Huland
Hepato-Gastroenterology|August 3, 1999
Immunotherapy of pulmonary metastatic renal cell carcinoma: success dependant on risk factors?E Huland, H Heinzer, H Huland
International Journal of Oncology|May 5, 2011
Supersensitive detection of prostate-specific antigen in lyophilisation-concentrated serumE Huland, A Haese, H Huland
Journal of Cancer Research and Clinical Oncology|January 1, 1997
Intratumoral depot interleukin-2 therapy inhibits tumor growth in Dunning adenocarcinoma of the prostate implanted subcutaneously in ratsS Hautmann, E Huland, H Huland
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Journal of Cancer Research and Clinical Oncology|January 1, 1992
Tumor-associated eosinophilia in interleukin-2-treated patients: evidence of toxic eosinophil degranulation on bladder cancer cellsE Huland, H Huland
Cancer Research|October 1, 1989
Local continuous high dose interleukin 2: a new therapeutic model for the treatment of advanced bladder carcinomaE Huland, H Huland
Der Urologe. Ausg. A|July 23, 2002
[Regional immunotherapy of metastatic renal cell carcinoma]H Heinzer, E Huland, H Huland
Folia Biologica|January 5, 2001
A comparison of systemic versus inhaled recombinant IL-2 administration for the treatment of metastatic renal cell carcinomaE Huland, H Heinzer, H Huland
Journal of Cancer Research and Clinical Oncology|January 1, 1994
Inhaled interleukin-2 in combination with low-dose systemic interleukin-2 and interferon alpha in patients with pulmonary metastatic renal-cell carcinoma: effectiveness and toxicity of mainly local treatmentE Huland, H Heinzer, H Huland
Der Urologe. Ausg. A|November 19, 2003
[Immunotherapy of renal cell carcinoma. With special emphasis on therapy of the elderly patient]H Heinzer, E Huland, H Huland
Anticancer Research|September 2, 1999
Treatment of pulmonary metastatic renal-cell carcinoma in 116 patients using inhaled interleukin-2 (IL-2)E Huland, H Heinzer, H Huland
Hepato-Gastroenterology|August 3, 1999
Immunotherapy of pulmonary metastatic renal cell carcinoma: success dependant on risk factors?E Huland, H Heinzer, H Huland
International Journal of Oncology|May 5, 2011
Supersensitive detection of prostate-specific antigen in lyophilisation-concentrated serumE Huland, A Haese, H Huland
Journal of Cancer Research and Clinical Oncology|January 1, 1997
Intratumoral depot interleukin-2 therapy inhibits tumor growth in Dunning adenocarcinoma of the prostate implanted subcutaneously in ratsS Hautmann, E Huland, H Huland
Pageof 6